C.R. Bard Inc. and a subsidiary could face a jury trial over claims by a Montana woman that its blood-clot trapping filter was flawed and linked to her injuries.
Maria Dalbotten sued Bard and Bard Peripheral Vascular Inc., alleging her G2 IVC filter migrated, pierced the vein, and fractured, leaving a fragment embedded in her heart.
An IVC filter is placed in the inferior vena cava, the largest vein of the body, to catch blood clots and prevent them from traveling from the legs to the heart or lungs.
The companies, owned by
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.